Guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet — RxCUI 1304111
RxNorm drug concept · Semantic clinical drug
RxCUI 1304111
Semantic clinical drug · SCD
● Current RxNorm concept 10 FDA products
11 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1304111
Official nameGuaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asguaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet
FDA products mapped10
Package NDCs mapped11
Reported Medicaid activity (SDUD)13 prescriptions · 1 state & territory Medicaid programs · latest period Q2 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
- I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
- You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
- Can I use the nasal spray if I have high blood pressure or heart disease?
🕸️ Concept Web — How Guaifenesin 400 MG / phenylephrine hydrochloride... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet
RxCUI 1304111 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Guaifenesin
5032IN -
Phenylephrine
8163IN -
Guaifenesin / phenylephrine
214597MIN -
Phenylephrine hydrochloride
8164PIN
-
Guaifenesin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Guaifenesin / phenylephrine Oral Tablet
378289SCDF -
Guaifenesin / phenylephrine hydrochloride Oral Tablet
2648658SCDFP -
Guaifenesin / phenylephrine Oral Product
1159114SCDG -
Guaifenesin / phenylephrine Pill
1159115SCDG -
Guaifenesin / phenylephrine hydrochloride Oral Product
2661648SCDGP -
Guaifenesin / phenylephrine hydrochloride Pill
2660754SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Guaifenesin / phenylephrine Oral Tablet
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Guaifenesin 400 MG
316015SCDC -
Phenylephrine hydrochloride 10 MG
996705SCDC
-
Guaifenesin 400 MG
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Guaifenesin 400 MG
SCDC · 316015 -
Phenylephrine hydrochloride 10 MG
SCDC · 996705 -
Guaifenesin / phenylephrine Oral Tablet
SCDF · 378289 -
Guaifenesin / phenylephrine hydrochloride Oral Tablet
SCDFP · 2648658 -
Guaifenesin / phenylephrine Oral Product
SCDG · 1159114 -
Guaifenesin / phenylephrine Pill
SCDG · 1159115 -
Guaifenesin / phenylephrine hydrochloride Oral Product
SCDGP · 2661648 -
Guaifenesin / phenylephrine hydrochloride Pill
SCDGP · 2660754
📦 FDA Products & Package NDCs
10 products · 11 package NDCs
11 package NDCs map to RxCUI 1304111 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00363-0542-01 | 1 BOTTLE, PLASTIC in 1 CARTON (0363-0542-01) / 30 TABLET, F... | Mucus Relief PE | Walgreen Company | 2006-04-15 |
| 00536-1309-07 | 1 BOTTLE, PLASTIC in 1 CARTON (0536-1309-07) / 30 TABLET in... | Rugby Chest Congestion Relief PE | Rugby Laboratories | 2020-09-09 |
| 00536-1309-08 | 1 BOTTLE, PLASTIC in 1 CARTON (0536-1309-08) / 60 TABLET in... | Rugby Chest Congestion Relief PE | Rugby Laboratories | 2020-09-09 |
| 36800-0989-50 | 1 BOTTLE in 1 CARTON (36800-989-50) / 50 TABLET in 1 BOTTLE | Topcare Chest Congestion and Sinus Congestion Relief PE | TOPCO ASSOCIATES LLC | 2006-06-05 |
| 46122-0700-71 | 1 BOTTLE in 1 CARTON (46122-700-71) / 50 TABLET in 1 BOTTLE | GNP Mucus Relief PE | AmerisourceBergen Drug Corp | 2022-01-13 |
| 49348-0774-09 | 1 BOTTLE in 1 CARTON (49348-774-09) / 50 TABLET in 1 BOTTLE | Sunmark Chest Congestion Relief PE PE | Strategic Sourcing Services LLC | 2019-08-29 |
| 63941-0986-50 | 1 BOTTLE in 1 CARTON (63941-986-50) / 50 TABLET in 1 BOTTLE | Always Save Mucus Relief PE | Valu Merch | 2023-02-06 |
| 69842-0997-60 | 1 BOTTLE in 1 CARTON (69842-997-60) / 60 TABLET in 1 BOTTLE | CVS Health Chest Congestion Relief PE | CVS Pharmacy, Inc. | 2006-06-05 |
| 70000-0141-01 | 1 BOTTLE, PLASTIC in 1 CARTON (70000-0141-1) / 50 TABLET, F... | Mucus Relief PE Sinus Congestion | Cardinal Health 110, LLC. DBA Leader | 2006-04-15 |
| 70677-1056-01 | 1 BOTTLE in 1 CARTON (70677-1056-1) / 50 TABLET in 1 BOTTLE | Foster and Thrive Chest Congestion Relief PE PE | Strategic Sourcing Services LLC | 2024-12-18 |
| 73057-0389-04 | 30 TABLET, COATED in 1 BOTTLE, PLASTIC (73057-389-04) | Pharbinex-PE | Ulai Health LLC | 2019-07-18 |
Observed labelers:
Rugby Laboratories (2) ·
Strategic Sourcing Services LLC (2) ·
AmerisourceBergen Drug Corp (1) ·
Cardinal Health 110, LLC. DBA Leader (1) ·
CVS Pharmacy, Inc. (1) ·
TOPCO ASSOCIATES LLC (1)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.